Wow,what was Bob smoking (2), $24 million loss!!!

We just got a $40 million debt against our assets. Shares down again. I still can't see how such a loss making company can make it with such a weak product portfolio and pipeline. Plus our commercially inexperienced management. Is this debt a good thing or not? I'm still concerned about my job security.

 

Working Pain Week here in Las Vegas with the team. They should rename this show - "Street Drugs Made Legal". What a rip off. A thousand ways to sell morphine, 100 year old drug, for a 1000 times it's cost. A few docs asking me about Oxyado and syringability out of politeness. You can tell I'm having a great time with the HQ folks who are out here to suck up to Dayno ("Dayno nothing!!" ) and have a week in Vegas.

 

Reagan - hot, Barb - not!!

 

Wait until the morphine launch disaster !

 

We're living it right now!!

 

So now the hot topic here at Wayne is that we can't package Arymo in time for the launch. Production/Marketing have screwed the packaging up.

 

You realize its not approved yet, genius?

 

Question for my Egalet buddies. Just got an offer for a job at Purdue Pharma. Should I abandon this sinking ship to only join another failing ship or stay here and hope that Arymo becomes the Viagra of the pain world?

 

The chances of Arymo getting above $50M maximum is zero percent.

 

I would stay put, and look for another opportunity. Purdue is just as much a dumpster fire as Eaglet. You need to hold out, and find a company you have a realistic chance of building a 5, or more, year career with.

 

Reading "The Arizona Relublic". Seems the FDA's original idea of certifying Docs to administer opiods, keep an electronic record of patients and scripts would go a long way to controlling opioid. Better option than ridiculous and expensive products like Oxyado and Arymo. Morphine is a buck a dose.

 

PDUFA date Oct 14. Management will start sales ASAP after that. #BullshitBob

 

Interesting comment. I'm currentlying working a mid Atlantic territory. Sprix and Oxyado suck. Especially Sprix. So the company is gambling on the FDA deciding that marketing expensive products like Arymo will trump restrictions on opioid Rx. With current Mylan debacle, I don't think so. Bob will be seen as just another greedy CEO.

 

It will be approved, generating scripts for branded ER morphine is the problem.
Nobody cares about the few crazy crush and snorters when its dirt cheap.

 

Yes, you're right. Oxyado is not gaining any traction in my territory because there's no real motivation to do anything about street abuse among my Docs. It's too far away from them to care. They all feel that they know their patients and they have the scripts under control. Unless the FDA or government really acts and introduces tighter laws that force the use of abuse deterrent drugs then Arymo will be a very marginal product.

I agree with the other post. Sprix really sucks. Most common objection is the pain IT causes on administration. We should drop it.

 

Hate to admit it but the moral here is complete dog s&@t. Not even considering the products, Egalet Management completely destroyed the culture once the first set of layoffs happened back in October after only 3 months in the field followed by Tim's epic email after the holidays. Once all of that happened ppl started working out of fear and this job wasn't fun anymore. I had such high hopes back at the Sprix launch meeting in DC cause they genuinely looked like they cared about the reps. Just look at all the top performers who are gone now. I hate to even be posting this because I was one of the original reps and was drinking the Egalet kool aid for so long. Now I'm done with this company and am looking for other opportunities. :/

 

Pat Shea's first meeting and communications - what a joke! Complete asshat. Don't think he'll be around for long. Folks at Clarus tell me he was a failure.

 

Rumor is that Bob met Pat at the low T clinic. The rest is history.......

 

Crap products, crap company, get the new drug approved so we can dump the stock before
any Rx results come in.

 

#BullshitBob, so we failed to get Arymo ER approved by the Oct 14 PDUFA date. FDA don't like it, nor do we. More management fails.